| 20-1119 |
Amarin Pharma, Inc., et al. v. Hikma Pharmaceuticals USA Inc., et al. |
Federal Circuit |
2021-02-16 |
Denied |
Amici (3)Response RequestedResponse WaivedRelisted (2) |
35-usc-103 graham-factors graham-v-john-deere hindsight-bias innovation innovation-protection nonobviousness-indicia objective-indicia obviousness-standard patent patent-law |
Whether a court must consider objective indicia of nonobviousness together with the other factors bearing on an obviousness challenge before making an… |
| 20-453 |
Consumer 2.0, Inc., dba Rently v. Tenant Turner, Inc. |
Federal Circuit |
2020-10-08 |
Denied |
Response Waived |
35-usc-101 alice-test conventional-features graham-v-john-deere hindsight-bias patent-eligibility preemption section-101 section-103 |
1) Whether preemption is a threshold and defining consideration that the lower courts must consider in determining whether a claimed invention is dire… |
| 20-158 |
SRAM, LLC v. FOX Factory, Inc. |
Federal Circuit |
2020-08-13 |
Denied |
Response Waived |
35-usc-103 commercial-success federal-circuit graham-v-john-deere nonobviousness objective-indicia patent-act patent-claim patent-law person-of-ordinary-skill secondary-considerations statutory-interpretation |
In Graham v. John Deere Co. of Kansas City, 383 U.S. 1 (1966), this Court recognized the pivotal importance of "objective indicia" of nonobviousness (… |
| 18-1289 |
Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc., et al. |
Federal Circuit |
2019-04-10 |
Denied |
Response Waived |
blocking-patent blocking-patent-doctrine commercial-success graham-v-john-deere long-felt-need objective-indicia objective-indicia-of-non-obviousness obviousness patent-law patent-law-doctrine-of-obviousness prior-art |
Whether the Federal Circuit erred in this case, as
it did in Acorda Therapeutics, Inc. v. Roxanne Laboratories, Inc., 903 F.3d 1310 (Fed. Cir. 2018), … |
| 18-1280 |
Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., et al. |
Federal Circuit |
2019-04-08 |
Denied |
Amici (5) |
blocking-patent-doctrine blocking-patents burden-of-proof graham-v-john-deere nonobviousness objective-indicia obviousness patent patent-law patent-obviousness pharmaceutical-innovation prior-art |
Under 35 U.S.C. § 103, a patent "may not be obtained . .. if the differences between the claimed invention and the prior art are such that the claimed… |
| 18-1274 |
In Re Urvashi Bhagat |
|
2019-04-04 |
Denied |
Amici (2)Response Waived |
35-usc-101 administrative-procedure administrative-procedure-act bilski-v-kappos federal-circuit-discretion graham-v-deere graham-v-john-deere judicial-discretion patent-eligibility patent-eligibility-35-usc-101 patent-law statutory-interpretation supreme-court-precedent uspto-discretion |
Whether the United States Patent and Trademark Office (USPTO) abused its discretion by refusing to allow claims that passed every single requirement o… |
| 18-692 |
Mylan Pharmaceuticals Inc., et al. v. UCB, Inc., et al. |
Federal Circuit |
2018-11-27 |
Denied |
Amici (3)Response Waived |
35-usc-103 double-patenting federal-circuit graham-factors graham-v-john-deere invention-disclosure lead-compound-test obviousness patent-eligibility patent-law patent-law-doctrine-of-double-patenting patent-validity prior-art |
1. This Court has long held that "no patent can issue for an invention actually covered by a former patent, especially to the same patentee." Miller v… |